Pfizer-BioNTech Win Prix Galien Canada Innovative Product Award for COMIRNATY

eAwazMedicine

KIRKLAND, QUEBEC and MAINZ, GERMANY – Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that COMIRNATY, the Pfizer-BioNTech COVID-19 Vaccine, has been named the 2023 winner of the Prix Galien Canada Innovative Product Award. COMIRNATY is indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in …

Pfizer-BioNTech to provide additional Covid-19 Vaccine Doses to Japan

eAwazMedicine

MAINZ — Pfizer Japan Inc. and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced conclusion of an agreement between the Japanese government and Pfizer Japan Inc. to supply an additional 10 million doses of the Omicron XBB.1.5-adapted COVID-19 vaccine (COMIRNATY Omicron XBB.1.5) for the special vaccination program in Japan which started this autumn. The vaccine doses to be supplied based on this agreement will be …